One additional country to benefit from EU-US mutual recognition agreement for inspections

On 26 June 2019, Germany was included into the mutual recognition agreement between the European Union and the United States Food and Drug Administration (FDA). The FDA thus confirmed the capability of this additional EU Member State to carry out good manufacturing practice (GMP) inspections at a level equivalent to the US. The agreement mutually recognizes inspections of manufacturing sites for human medicines conducted in the different territories.